Metlife (0K0X) Share Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0K0X Analyst Ratings

Strong Buy

12 Buy

2 Hold

0 Sell

Based on 14 analysts giving stock ratings to

Metlife

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0K0X Stock 12 Month Forecast

Average Price Target

$94.43

▲(23.63% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for Metlife in the last 3 months. The average price target is $94.43 with a high forecast of $108.00 and a low forecast of $84.00. The average price target represents a 23.63% change from the last price of $76.38.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"71":"$71","90":"$90","109":"$109","80.5":"$80.5","99.5":"$99.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":108,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$108.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":94.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$94.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":84,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$84.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[71,80.5,90,99.5,109],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.62,83.64923076923077,85.67846153846155,87.70769230769231,89.73692307692308,91.76615384615386,93.79538461538462,95.82461538461538,97.85384615384615,99.88307692307693,101.91230769230769,103.94153846153847,105.97076923076924,{"y":108,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.62,82.60538461538462,83.59076923076924,84.57615384615386,85.56153846153846,86.54692307692308,87.5323076923077,88.51769230769231,89.50307692307693,90.48846153846155,91.47384615384615,92.45923076923077,93.44461538461539,{"y":94.43,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.62,81.80307692307693,81.98615384615385,82.16923076923078,82.35230769230769,82.53538461538461,82.71846153846154,82.90153846153846,83.08461538461539,83.26769230769231,83.45076923076923,83.63384615384615,83.81692307692308,{"y":84,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":78.907,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.05,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.769,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.334,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.175,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.542,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.344,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.366,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.68,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.094,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.488,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.074,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.62,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$108.00

Average Price Target$94.43

Lowest Price Target$84.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jory Endura

TR | OpenAI - 4o

$86

Buy

12.59%

Upside

Reiterated

11/01/25

AI Generated ArticleAI Generated Article

Joshua Shanker

Bank of America Securities

$100→$104

Buy

36.16%

Upside

Reiterated

10/13/25

Bank of America Securities Reaffirms Their Buy Rating on Metlife (MET)

Elyse Greenspan

Wells Fargo

$95→$96

Buy

25.69%

Upside

Reiterated

10/08/25

Wells Fargo Reaffirms Their Buy Rating on Metlife (MET)

Alex Scott

Barclays

$93→$98

Buy

28.31%

Upside

Reiterated

10/08/25

Barclays Reaffirms Their Buy Rating on Metlife (MET)

Bob Huang

Morgan Stanley

$94→$97

Buy

27.00%

Upside

Reiterated

10/07/25

MetLife price target raised to $97 from $94 at Morgan StanleyMetLife price target raised to $97 from $94 at Morgan Stanley

Jimmy Bhullar

J.P. Morgan

$94→$93

Buy

21.76%

Upside

Reiterated

10/02/25

J.P. Morgan Remains a Buy on Metlife (MET)

Jack Matten

BMO Capital

$82→$84

Hold

9.98%

Upside

Reiterated

09/30/25

BMO Capital Keeps Their Hold Rating on Metlife (MET)

John Barnidge

Piper Sandler

$94→$84

Hold

9.98%

Upside

Downgraded

09/19/25

Analysts Have Conflicting Sentiments on These Financial Companies: Radian Group (NYSE: RDN) and Metlife (NYSE: MET)

Tracy Benguigui

Wolfe Research

$95

Buy

24.38%

Upside

Initiated

09/15/25

MetLife initiated with an Outperform at Wolfe ResearchMetLife initiated with an Outperform at Wolfe Research

Kevin Heal

Argus Research

$90

Buy

17.83%

Upside

Reiterated

08/29/25

Metlife (MET) Gets a Buy from Argus Research

Andrew Kligerman

TD Cowen

$90→$91

Buy

19.14%

Upside

Reiterated

08/22/25

TD Cowen Sticks to Their Buy Rating for Metlife (MET)We reiterate Buy.

Ryan Krueger

KBW

$94→$92

Buy

20.45%

Upside

Reiterated

08/12/25

KBW Keeps Their Buy Rating on Metlife (MET)

Suneet Kamath

Jefferies

$100→$103

Buy

34.85%

Upside

Reiterated

08/11/25

Jefferies Reaffirms Their Buy Rating on Metlife (MET)

Thomas Gallagher

Evercore ISI

$110→$108

Buy

41.40%

Upside

Reiterated

08/08/25

Evercore ISI Sticks to Their Buy Rating for Metlife (MET)

Michael Ward CFA

UBS

$94→$91

Buy

19.14%

Upside

Reiterated

08/07/25

Metlife (MET) Receives a Buy from UBS

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jory Endura

TR | OpenAI - 4o

$86

Buy

12.59%

Upside

Reiterated

11/01/25

AI Generated ArticleAI Generated Article

Joshua Shanker

Bank of America Securities

$100→$104

Buy

36.16%

Upside

Reiterated

10/13/25

Bank of America Securities Reaffirms Their Buy Rating on Metlife (MET)

Elyse Greenspan

Wells Fargo

$95→$96

Buy

25.69%

Upside

Reiterated

10/08/25

Wells Fargo Reaffirms Their Buy Rating on Metlife (MET)

Alex Scott

Barclays

$93→$98

Buy

28.31%

Upside

Reiterated

10/08/25

Barclays Reaffirms Their Buy Rating on Metlife (MET)

Bob Huang

Morgan Stanley

$94→$97

Buy

27.00%

Upside

Reiterated

10/07/25

MetLife price target raised to $97 from $94 at Morgan StanleyMetLife price target raised to $97 from $94 at Morgan Stanley

Jimmy Bhullar

J.P. Morgan

$94→$93

Buy

21.76%

Upside

Reiterated

10/02/25

J.P. Morgan Remains a Buy on Metlife (MET)

Jack Matten

BMO Capital

$82→$84

Hold

9.98%

Upside

Reiterated

09/30/25

BMO Capital Keeps Their Hold Rating on Metlife (MET)

John Barnidge

Piper Sandler

$94→$84

Hold

9.98%

Upside

Downgraded

09/19/25

Analysts Have Conflicting Sentiments on These Financial Companies: Radian Group (NYSE: RDN) and Metlife (NYSE: MET)

Tracy Benguigui

Wolfe Research

$95

Buy

24.38%

Upside

Initiated

09/15/25

MetLife initiated with an Outperform at Wolfe ResearchMetLife initiated with an Outperform at Wolfe Research

Kevin Heal

Argus Research

$90

Buy

17.83%

Upside

Reiterated

08/29/25

Metlife (MET) Gets a Buy from Argus Research

Andrew Kligerman

TD Cowen

$90→$91

Buy

19.14%

Upside

Reiterated

08/22/25

TD Cowen Sticks to Their Buy Rating for Metlife (MET)We reiterate Buy.

Ryan Krueger

KBW

$94→$92

Buy

20.45%

Upside

Reiterated

08/12/25

KBW Keeps Their Buy Rating on Metlife (MET)

Suneet Kamath

Jefferies

$100→$103

Buy

34.85%

Upside

Reiterated

08/11/25

Jefferies Reaffirms Their Buy Rating on Metlife (MET)

Thomas Gallagher

Evercore ISI

$110→$108

Buy

41.40%

Upside

Reiterated

08/08/25

Evercore ISI Sticks to Their Buy Rating for Metlife (MET)

Michael Ward CFA

UBS

$94→$91

Buy

19.14%

Upside

Reiterated

08/07/25

Metlife (MET) Receives a Buy from UBS

Stocks with the Highest Top Analyst Consensus in the Financial Sector

xxx

Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Metlife

1 Month

xxx

Success Rate

24/35 ratings generated profit

Average Return

+2.32%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 68.57% of your transactions generating a profit, with an average return of +2.32% per trade.

3 Months

xxx

Success Rate

23/35 ratings generated profit

Average Return

+4.19%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.71% of your transactions generating a profit, with an average return of +4.19% per trade.

1 Year

Ryan KruegerKBW

Success Rate

27/31 ratings generated profit

Average Return

+16.48%

reiterated a buy rating 3 months ago

Copying Ryan Krueger's trades and holding each position for 1 Year would result in 87.10% of your transactions generating a profit, with an average return of +16.48% per trade.

2 Years

xxx

Success Rate

27/32 ratings generated profit

Average Return

+16.53%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 84.38% of your transactions generating a profit, with an average return of +16.53% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0K0X Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0K0X has received 29 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 0K0X average Analyst price target in the past 3 months is 94.43.

Each month's total comprises the sum of three months' worth of ratings.

0K0X Financial Forecast

0K0X Earnings Forecast

Next quarter’s earnings estimate for 0K0X is $2.39 with a range of $2.25 to $2.51. The previous quarter’s EPS was $2.34. 0K0X beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 65.60% of the time in the same period. In the last calendar year 0K0X has Preformed in-line its overall industry.

0K0X Sales Forecast

Next quarter’s sales forecast for 0K0X is $19.15B with a range of $18.25B to $19.73B. The previous quarter’s sales results were $17.36B. 0K0X beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 79.60% of the time in the same period. In the last calendar year 0K0X has Preformed in-line its overall industry.

0K0X Stock Forecast FAQ

What is GB:0K0X’s average 12-month price target, according to analysts?

Based on analyst ratings, Metlife’s 12-month average price target is 94.43.

What is GB:0K0X’s upside potential, based on the analysts’ average price target?

Metlife has 23.63% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Metlife a Buy, Sell or Hold?

Metlife has a consensus rating of Strong Buy, which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.

What is Metlife’s share price target?

The average share price target for Metlife is 94.43. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $108.00 ,and the lowest forecast is $84.00. The average share price target represents 23.63% Increase from the current price of $76.38.

What do analysts say about Metlife?

Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of Metlife?

To buy shares of GB:0K0X, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Metlife (0K0X) Share Forecast & Price Target

0K0X Analyst Ratings

0K0X Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Metlife

0K0X Analyst Recommendation Trends

0K0X Financial Forecast

0K0X Earnings Forecast

0K0X Sales Forecast

0K0X Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts